Techstart Ventures is a Belfast-based venture capital firm established in 2014 that backs early-stage startups from inception to pre-seed. It writes initial checks of up to £750,000 and maintains strong follow-on capacity to support ambitious teams as they grow. The firm leads, co-leads, or selectively co-invests, partnering with founders who bring unique insights and global ambition. Its approach emphasizes hands-on collaboration and rigorous value creation to help portfolio companies scale. While the focus spans Scotland and Northern Ireland, Techstart maintains a globally oriented outlook to identify and nurture high-potential opportunities worldwide.

Clarendon Fund Managers is a Belfast-based venture capital fund manager that backs growth-oriented small and medium-sized enterprises in Northern Ireland through two core vehicles: the Co-Investment Fund and the Investment Fund for Northern Ireland. It conducts co-investments with business angels and private investors, typically providing initial checks of £50,000 to £250,000 with follow-on support, and targets exits in roughly five to seven years. Since its inception in 2001, the firm has backed a broad portfolio of companies and supports growth across start-up, early, and expansion stages. The company is authorised and regulated by the Financial Conduct Authority.

SOSV is a global venture capital firm that provides early-stage and seed investments alongside structured accelerator programs and deeply resourced facilities to accelerate product development. Focused on deep tech, human and planetary health, and cross-border software, SOSV backs startups from pre-seed onward and runs programs that accelerate technical development, regulatory strategy, and fundraising. The firm maintains labs and engineering spaces with specialist staff in multiple regions, including the United States and Asia, to support portfolio companies in biosafety, chemistry, mechatronics, analytics, and electrical engineering. Programs such as HAX and other live events offer founders access to prototyping, testing, and investor networks. Annually, SOSV makes around sixty pre-seed investments (up to roughly $550k each) and participates in numerous follow-on rounds, leveraging a global portfolio and extensive co-investor network to help deeply technical startups scale and reach markets.

Act Venture Capital is a Dublin-based technology-focused venture capital firm that backs early to growth-stage companies across Ireland and Europe. Founded in 1994, it provides capital and strategic support to help founders scale category-defining businesses in software, IT infrastructure, communications, Internet and mobile, and healthcare. The firm manages multiple funds and has raised hundreds of millions of euros, deploying capital from seed to growth stages. It emphasizes a hands-on approach and leverages a broad network of US and European investors and founders to help portfolio companies expand globally. Act Venture Capital works with portfolio companies to build investor networks, scale operations, and access strategic resources, with support from partners including the European Investment Fund.

Frontline Ventures is a venture capital firm headquartered in Dublin with offices in London and San Francisco, investing in early- and growth-stage business-to-business software companies across Europe and the United States. It focuses on helping globally ambitious B2B firms expand transatlantically, leveraging a hands-on approach and a cross-Atlantic network of operators and founders to support expansion milestones. The team comprises entrepreneurs and industry veterans with experience scaling ventures, aiming to add strategic value beyond capital and to guide portfolio companies through company-defining moments.

Par Equity is a venture capital and private equity firm backed by Scottish Enterprise, based in Edinburgh with an office in San Francisco. It specializes in early‑stage and growth investments in technology companies, including software, deep tech and digital health, targeting opportunities in Scotland, Northern England and Northern Ireland, with cross‑border expansion between the United Kingdom and the United States. The firm funds proprietary technology and proven products poised for international growth, supporting UK companies expanding to the United States and US entrants seeking a UK presence. Typical investments range from £0.25 million to £2.5 million, with enterprise values up to about £10 million. It also provides angel capital to investee companies and focuses on cross‑border deals to accelerate scale.

Kernel Capital is an independent investment firm based in Ireland that backs technology companies across the island of Ireland, including both the Republic of Ireland and Northern Ireland. It targets growth-stage as well as seed and early-stage opportunities, often leading Series A rounds and engaging in co-investments to support expansion and scaling. The firm emphasizes more than capital by providing strategic guidance, market access, and a network of over 200 C-level executives and 1,200 portfolio alumni to help portfolio companies recruit talent, enter international markets, and accelerate revenue growth. Kernel Capital has facilitated two IPOs and 25 trade sales, reflecting its track record in helping companies reach significant milestones. The organization supports business-model development, strategic planning, and connections to potential investors, customers, and partners to create long-term value for its portfolio.

Elkstone Partners is an Irish investment firm focused on venture capital, real estate, and cash management. It serves institutional investors, financial advisors, and a broad network of entrepreneurs and the Irish diaspora, aiming to provide access to opportunities, diversification, and tailored investment solutions. The firm concentrates on the Irish market with a growing portfolio of notable companies and emphasizes collaboration with professional partners to deliver investment performance and value. It is regulated by the Central Bank of Ireland.

Fountain Healthcare Partners is an Ireland-headquartered private equity and venture capital firm specializing in the life sciences sector. Based in Dublin with an office in New York, it focuses on companies developing biotechnology, biopharmaceuticals, specialty pharmaceuticals, medical devices, and diagnostics, investing primarily in Europe and the United States. The firm supports early-stage through growth-stage companies, providing capital and strategic guidance to help advance therapies and enabling technologies through key milestones. Its team combines scientific and business expertise to assess science, market dynamics, and regulatory pathways, with a track record of active involvement and governance, including board participation. Fountain Healthcare Partners seeks to back visionary founders addressing unmet medical needs and to accelerate meaningful healthcare innovations over multi-year horizons.

Seroba Life Sciences is a Dublin-based venture capital firm focused on life sciences and medical technology. Founded in 2002, it invests in therapeutics, diagnostics, and medical devices across Western Europe and North America, from seed through late-stage development. The firm typically leads or co-leads investments, often in the range of several million euros, and provides support through inception, clinical development, regulatory approvals, intellectual property creation, and market launch. It emphasizes backing ambitious entrepreneurs and innovative technologies that aim to improve patient outcomes, with offices in Ireland and the United Kingdom to support global opportunities.

OakNorth is a UK-based digital bank and lending platform founded in 2015 to serve growth-focused small-to-mid-sized businesses underserved by traditional banks. It provides bespoke debt financing for growth, including commercial real estate and cash-flow-based mid-market lending, supported by data-driven analytics and forward-looking scenario planning to speed decision-making and reduce reliance on historical financials. Operating in the United Kingdom and the United States with a New York-based team, OakNorth emphasizes speed, transparency, and tailored service, and offers analytics through OakNorth Analytical Intelligence to help lenders manage risk and promote sustainable lending.

Delta Partners is a Dublin-based venture capital firm that invests in early-stage technology companies in Ireland and the United Kingdom. Founded in 1994, it maintains a London office and emphasizes long-term, partner-led support to founders throughout the startup journey. The firm backs spin-offs and product- or service-based technology businesses across information technology, information and communications technology, healthcare, life sciences, medical technology, and related sectors, with a focus on companies emerging from campus or international development teams. Delta Partners seeks to help founders establish strong foundations and milestone-driven plans as they scale.

Growing Capital is a venture capital firm based in Dublin, Ireland, specializing in seed and early-stage investments in software and business-to-business startups. Since 2015 it has backed more than 25 companies, including exits such as Glofox and Caragon and unicorns like Flipdish and ScalaPay. The firm typically makes initial investments of around €50,000–€100,000 and emphasizes swift due diligence, transparent terms, and non-intrusive support. It focuses on Irish startups and collaborates with initiatives such as Enterprise Ireland New Frontiers to identify ambitious founders with scalable ideas, aiming to help them build strong teams and reach meaningful growth while upholding integrity and respect in its engagements.

Sure Valley Ventures is a London-based venture capital firm focused on early-stage investments in artificial intelligence and software startups across the United Kingdom and Ireland. The firm is entrepreneur-led, with former founders among its investors who bring decades of experience to identify and support high-potential AI software companies using foundational AI technologies to solve real-world industry problems. Notable portfolio activity includes investments in Ralio, a leading on-device visual AI platform, and Getvisibility, an AI data security company.

COSIMO Ventures is an early-stage venture capital firm focused on disruptive technology, with activities in Ireland and the United Kingdom and offices in Boston and Dublin. The team brings extensive entrepreneurial and investing experience and works with management teams to accelerate growth and help Irish and UK technology companies reach global markets, including expansion into the United States. As technology pioneers, COSIMO Ventures emphasizes value creation for early-stage companies and supports founders with strategic guidance, networks, and hands-on operational insight to help them build scalable, world-leading businesses.

Lough Shore Investments is a Belfast-based venture capital firm that backs technology startups in the web, mobile and enterprise sectors, focusing on opportunities in Northern Ireland and Ireland. It partners with ambitious management teams to accelerate growth and position portfolio companies for successful exits or public listings. The firm concentrates on high-potential ventures in the region and has a stated objective of helping ten portfolio companies reach exit or IPO milestones.

eDot Invest is a Dublin-based venture capital firm founded in 2014 that specializes in early-stage technology investments in Europe. The firm provides capital and ongoing support to startups to help them develop products, expand operations, and scale their businesses.

Crescent Capital is a Belfast-based venture capital and private equity firm that invests in Northern Ireland companies across information technology, life sciences, manufacturing, and related technology sectors. Founded in 1995, the firm provides growth-focused equity and minority or majority investments to early- and development-stage companies, with a preference for transformative ventures. Crescent Capital adopts a hands-on approach, often taking board seats and leveraging a broad network to support management teams, cash management, sales, and customer insight. The firm targets exits within five to seven years, typically through trade sales or other equity realizations, and maintains a regional focus on Northern Ireland, occasionally operating from its offices in Belfast and London. The objective is to accelerate growth for high-potential businesses through practical, experienced guidance and strategic capital.

Salica Investments is a London-based venture capital firm founded in 2014 that makes equity and debt investments across complementary sectors and stages. The firm provides global networks and guidance from seed to scale and supports both early- and later-stage ventures, secondary investments, and growth debt. It is described as a continuation of Hambro Perks' mission, focusing on global growth opportunities and delivering strong returns for investors. Salica emphasizes innovation across finance, healthcare, sustainability, and productivity, and leverages its network to support portfolio growth and progress.

Irrus Investments is an Irish business angel network based in Limerick that supports early-stage Irish companies in medical devices, diagnostics, digital healthcare, and life sciences. It provides mentorship and funding to startups, often ranging from €500,000 to €1 million, and frequently collaborates with venture capital firms for larger rounds. The network emphasizes practical guidance and entrepreneurship across Ireland, and operates on a non-profit basis, serving as a resource for both investors seeking opportunities and startups seeking capital to realize their plans.

European Investment Bank is a key financial institution of the European Union that finances projects across Europe and beyond to promote sustainable development. It focuses on climate action, innovation, regional development, and infrastructure, providing financing through loans, guarantees, and advisory services to public and private sectors; supports large-scale infrastructure, technology development, and access to capital for enterprises; aligns with EU priorities such as the European Green Deal and digital transformation, including initiatives like InvestEU and Ukraine's recovery. It operates globally with a significant presence in the EU and neighboring regions, aiming to boost growth, create jobs, and improve living standards, while upholding transparency, accountability, and stakeholder engagement.

Enterprise Equity is an Irish venture capital firm that provides early-stage and growth capital to technology-focused companies with international expansion ambitions. With offices in Dublin, Cork, Galway, Dundalk, and San Francisco, the firm supports Irish and internationally oriented portfolio companies across software, high-technology manufacturing, and medical devices. It has a track record spanning more than 25 years and has invested in over 80 companies, with total investments exceeding €50 million. The firm manages multiple funds and participates in the AIB Seed Capital Fund, which has about €53 million available for seed and early-stage investments, typically investing between €0.25 million and €1.5 million per company. Enterprise Equity also provides strategic guidance, governance support, and leverages international networks to help portfolio companies grow, aiming to help Irish firms scale internationally.

Technology Crossover Ventures (TCV) is a technology-focused growth equity firm based in Menlo Park, California, founded in 1995. The firm provides capital to growth-stage private and public technology companies and supports management teams with data-driven insights, sector expertise, access to top talent, and connections with category leaders. It invests across software, internet, fintech, consumer services, financial services, healthcare, cybersecurity, big data, e-commerce, infrastructure, and other technology-enabled sectors. Since inception, TCV has invested over $17 billion in more than 350 technology companies, with numerous IPOs and strategic acquisitions among its portfolio.

BGF is a growth capital provider in the UK and Ireland aiming to help SMEs scale, with a focus on deep tech and life sciences. Founded in 2011, it has deployed over £4.5 billion in growth capital, assisting more than 600 businesses and helping over 280 achieve exits. It typically provides patient capital without taking controlling equity and offers strategic guidance, access to networks, and follow-on funding support as part of a long-term growth partnership.

Lightstone Ventures is a California-based global venture capital firm that targets life science and healthcare companies, with emphasis on biopharmaceuticals, medical devices, and related technologies. It focuses on early- to late-stage investments in startups and growth-stage companies developing personalized medicines, targeted therapeutics, breakthrough therapies, and disruptive technologies across areas such as CNS, immunology, oncology and ophthalmology. The firm provides capital as well as strategic guidance and hands-on support through a seasoned team with extensive company-building experience. Based in the United States, Lightstone leverages a global network to help portfolio companies navigate development, regulatory and commercialization milestones from startup to market. The approach combines patient capital with a long-term perspective and a track record of exits and IPOs in the life sciences sector.

Business Venture Partners is an Ireland-based private equity and corporate finance firm, founded in 2004. The firm provides flexible investment options from seed equity to project financing for Irish companies across sectors including energy, healthcare, engineering, climate action, mobility and information technology. It employs both equity and debt financing to support growth, expansion, and strategic initiatives, with a focus on sustainability and shareholder value. The team delivers hands-on support to founders and management, helping accelerate growth, navigate international expansion, and build resilient businesses. With roots in corporate finance advisory for SMEs and owner-managed businesses, BVP combines industry knowledge with venture investing to back high-potential ventures and enable sustainable, long-term performance in the Irish market.

Founded in 1997, MVM Partners is a healthcare-focused private equity and venture capital firm with offices in Boston and London and a presence in the San Francisco Bay Area. It pursues growth equity and venture opportunities across medical technology, biotechnology, pharmaceuticals, diagnostics, digital health, and healthcare services, investing in companies worldwide. The firm supports early-stage and growth opportunities, typically in the tens of millions of dollars per portfolio company, and seeks differentiated technologies addressing unmet medical needs. It emphasizes collaborative partnerships with management teams to accelerate growth and aims to achieve value-creating exits through acquisitions and public offerings. The firm's track record includes multiple successful portfolio exits across medical devices, life sciences tools, and related healthcare sectors.

CircleRock Capital is a London- and Dublin-based venture capital firm founded in 2020 that operates as a multi-stage investor focused on technology companies across Europe, the UK, and the US. The firm pursues a conviction-driven, deal-by-deal approach, co-investing with others to back Seed through Series B rounds and seeking meaningful ownership. Typical initial tickets range from €500,000 to €5 million. CircleRock does not typically lead rounds or take board seats and has built a portfolio of about 25 companies. The firm emphasizes leveraging its commercial and talent networks to access competitive opportunities. Its footprint across Europe and North America reflects a global technology investment strategy.

Treo Ventures is a healthcare-focused venture capital firm established in 2018 and based in Santa Clara, California, with operations in Silicon Valley and Ireland. The firm invests globally in early to commercial-stage companies advancing medical devices, digital health, and therapeutic technologies that address unmet clinical needs, particularly in cardiovascular, orthopedic, and neuromodulation applications. It brings decades of healthcare investment and operating experience and provides strategic guidance to portfolio companies, supported by an accelerator program named NuXcel. Treo Ventures seeks high-growth opportunities and collaborates with portfolio companies such as ShiraTronics, Avivomed, and SecondWave Systems to accelerate product development and market adoption.

General Catalyst is a venture capital firm that funds early-stage and growth companies across sectors including consumer, enterprise software, fintech, crypto, and healthcare. Based in San Francisco with offices in Cambridge, Massachusetts and other locations, it provides capital and strategic guidance to help entrepreneurs build scalable, durable businesses. The firm emphasizes the use of technology, including artificial intelligence, to accelerate growth and drive meaningful impact. General Catalyst partners with management teams to support product development, go-to-market strategies, and organizational growth, aiming to back companies with potential for wide adoption and long-term value creation, rather than focusing solely on near-term exits.

Ascension is a large non-profit Catholic health system operating across multiple states with a network of hospitals and health facilities, supported by about 23,000 providers and 99,000 associates. Guided by a mission to deliver compassionate, personalized care to all, with special attention to people living in poverty and those most vulnerable, Ascension offers patient portals, interpreters, community health needs assessments, genetic testing initiatives, and personalized care programs. It provides online bill payment and various patient services, and pursues programs such as music therapy for NICU babies, aiming to improve access, quality, and outcomes for diverse communities.

The European Innovation Council is a Brussels-based European Union organization established in 2018 to support deep‑tech innovation by helping startups, researchers and technology transfer activities move ideas toward market. It operates a portfolio of programs including Pathfinder, Accelerator, Transition, STEP Scale Up and Pre-Accelerator, and collaborates with partners to provide funding, mentorship and resources across the innovation lifecycle. The council emphasizes high-impact, science‑driven technologies with broad societal benefit and promotes inclusion, with initiatives to involve women‑led projects. It engages the wider ecosystem through awards, events and community initiatives and monitors impact through data platforms. By coordinating with private investors and other stakeholders, it aims to accelerate the scale-up of European deep‑tech firms and strengthen Europe’s position in global technology leadership.

57 Stars is a global independent asset manager specializing in private equity and venture capital investments, focusing on primary and secondary private equity partnerships and co-investments outside the United States, with emphasis on emerging markets. The firm applies a rigorous, analytical approach and a global perspective to identify opportunities across direct investments, funds of funds, and co-investments, serving institutional clients and pursuing responsible investing and long-term growth.

Hercules Capital is a specialty finance company that acts as a non-bank lender and business development company, providing venture debt and related capital to venture-backed technology, life sciences, and sustainable technology companies. With more than a decade of experience, it offers senior secured and structured debt, often with warrants, to support growth, acquisitions, recapitalizations, and pre-IPO needs. The company focuses on cash-flow based financing and asset-based facilities such as accounts receivable lines, equipment loans, and working capital facilities, tailoring structures to fit a portfolio company's capital plan and milestones. It primarily serves United States based, venture-backed firms across software, hardware, healthcare, energy technology, and related sectors, spanning early to late-stage growth. The organization positions itself as a flexible partner that helps portfolio companies reach milestones and potentially pursue IPOs or M&A exits, backed by a diversified portfolio of hundreds of companies.

True Ventures is a Silicon Valley-based venture capital firm founded in 2005 and headquartered in Palo Alto, California, that backs early-stage technology startups. It concentrates on seed and Series A investments and supports founders with a hands-on, long-term approach through the True Platform, a set of programs designed to inspire professional and personal growth. The firm manages multiple funds and has raised billions in capital, backing more than 350 companies and helping to create tens of thousands of jobs worldwide. True Ventures is known for providing operational and strategic support across its portfolio and for a disciplined focus on founders and market-changing ideas. The firm was recognized as Venture Firm of the Year in 2018 by the National Venture Capital Association, reflecting its track record in helping startups scale.

Zoosh Group is a product studio and investment partner that supports early-stage startups by combining venture guidance with hands-on product development. It offers digital product design, build and development, and ongoing support from conception to launch and scale, helping teams establish new revenue streams and recruit and structure teams. The group emphasizes cloud-focused, design-led solutions and operates as a Microsoft Business Central and technology partner, delivering tailored ERP and integrations, automation, and upgrades to improve efficiency and drive data-driven insights. With over 30 design and tech experts, Zoosh has developed more than 50 cloud propositions for 40+ customers globally and maintains a partnership-driven approach. Founded in 2017 and headquartered in Ireland, the company serves entrepreneurs by combining venture expertise with product studio capabilities to maximize digital product success.

Lucey Fund is a venture capital firm based in Dublin, Ireland, founded in 2011, that invests in technology ventures and supports entrepreneurs who may not have prior technology experience but possess industry knowledge. It funds the development of first scalable, secure, viable products and provides a multidisciplinary team of technology, marketing and sales experts to research, design, build, host, finance and commercialize the product and the business.

PXN Ventures is the corporate venture capital arm of Pxn Group, based in Manchester, United Kingdom. It targets startups operating in artificial intelligence, gaming, health tech, life sciences, and cybersecurity, seeking to provide more than capital by offering founder support through dedicated operating partners drawn from established companies. The firm emphasizes a holistic approach to venture investing, delivering strategic guidance, governance updates, and access to networks to help portfolio companies scale. PXN Ventures focuses on growth-oriented opportunities in the North of England, Northern Ireland, and Scotland, aiming to be a world-class investor through deep experience and broad connections. The firm operates under Financial Conduct Authority regulation (FRN 817345), reflecting a compliant approach to corporate venture investing.

Wayra is Telefónica's corporate venture capital and global open innovation hub. It connects startups with Telefónica's business units through a venture-client model and open-innovation programs, enabling joint opportunities and faster scale. The group operates across 10 countries, including Argentina, Brazil, Chile, Colombia, Germany, Mexico, Peru, Spain, the United Kingdom, and Venezuela, to engage ecosystems and bring together entrepreneurs, investors, and industry leaders. Wayra has invested in more than 1,200 startups with total funding exceeding €260 million, focusing on digital health, travel tech, and other technology-enabled sectors. Through collaborations with large organizations such as AstraZeneca and Kunsen, and partnerships like TUI Care Foundation and Target 8.9 for the TUI Futureshapers initiative, Wayra helps accelerate growth and drive impact for both startups and Telefónica's business units.

ACF Investors is a United Kingdom-based venture capital firm that co-invests with syndicates of sector-focused angel investors to fund and scale early-stage businesses. It operates two funds, the Angel CoFund and the Delta Fund, and emphasizes meaningful investments by backing startups alongside committed angels, often with new participants in each round. Based in the United Kingdom, the firm leverages its network to provide post-investment support to portfolio companies and pursues capital growth across its investments. Since its 2011 launch, ACF Investors has backed numerous UK startups and built a growing portfolio through successive rounds, reflecting its long-standing co-investment approach.

Draper Esprit is a Europe-focused private equity and venture capital firm with offices in London, Cambridge, Dublin, Helsinki, and Paris. It backs technology-oriented businesses and healthcare across Europe at multiple stages—from seed and Series A to growth and pre-IPO—placing both minority and majority stakes. The firm pursues direct investments and secondary opportunities in sectors including software, hardware, fintech, internet, digital health, and other tech-enabled areas, targeting companies in the UK, Ireland, and wider Europe.

Finistere Ventures is a venture capital firm focused on agriculture, agtech and life sciences. Founded in 2005, it operates from the West Coast with offices in San Diego and Newport Beach, California, and additional locations in Palo Alto, Menlo Park, Dublin and Tel Aviv, reflecting a global investment footprint. The firm backs private companies across the United States and selected international markets, supporting opportunities from early stage to growth stage in sectors such as agricultural biotechnology, crop protection, precision agriculture, food technology, plant and animal health, bioproducts and sustainability tools. Finistere engages with portfolio companies to accelerate product development, scale operations and access strategic partnerships, often through co-investment and mentorship networks. By leveraging global networks and sector expertise, the firm seeks to advance productivity, food security and environmental sustainability while building companies with meaningful potential for value creation and exits.

CIBC Innovation Banking is the North American banking arm of CIBC focused on supporting the growth of the innovation economy. It offers venture banking, growth banking, sponsor finance, and fund finance to technology, software, AI, healthcare, and life sciences companies from seed to IPO. Backed by CIBC and with over 25 years of experience, it has deployed roughly $12 billion in growth capital to more than 800 entrepreneurs and investors and serves millions of clients globally through a global team that emphasizes relationship-building and market insights.

Cross Atlantic Capital Partners is a Radnor, Pennsylvania-based venture capital firm focused on technology-driven companies across the United States, Ireland, and the United Kingdom. It targets early to mid-stage opportunities in software, IT services, telecommunications, financial services, and other technology-enabled sectors, often backing companies with patented know-how or distinctive expertise. The team combines deep operational experience, with multiple partners having held CEO or COO roles, and maintains active involvement on portfolio company boards. It leverages an extensive cross-Atlantic network and relationships with strategic partners, lenders, and industry groups to support growth and value creation. The firm seeks opportunities with large markets and potential to achieve meaningful revenue or valuation milestones within three to five years, providing strategic guidance and board-level oversight to help accelerate development and scale.

Continuous Ventures is a Dublin-based venture studio and external innovation partner that builds startups from market validation to MVP, serving founders needing operators and momentum, corporate innovators seeking speed, and investors seeking progress. It uses embedded teams that ship products, test rapidly, and align stakeholders to measurable outcomes, functioning as an external innovation arm for enterprises and providing foundational tech and AI capabilities to scale. The company operates regionally with teams across North America and Europe and maintains offices in Dubai and New York to support local execution and global deployment. Its focus areas include artificial intelligence, fintech, and environmental tech, with accelerator and venture support designed to nurture early-stage ventures through structured development and strategic guidance.

Malin Corporation is an Irish-based investment company focused on life sciences and healthcare technology. It provides long-term capital and strategic operational support to private companies in oncology, immunology, and genetic diseases to help them realize value, reach commercial potential, and improve patient outcomes. Headquartered in Dublin with offices in New Haven, Connecticut and Research Triangle Park, North Carolina, Malin combines capital with hands-on involvement to accelerate development and value creation for innovative therapies and technologies in dynamic segments of the life sciences sector.

Impax Asset Management Group is a specialist asset manager focused on investing in the transition to a more sustainable global economy. It offers a diversified suite of investment solutions across asset classes, including long-only equity, fixed income, infrastructure and smart beta, and manages funds and accounts for institutional and private investors. The firm prioritizes environmental markets such as alternative energy, water and waste and integrates sustainability considerations into its research and investment process. It operates globally, providing stewardship insights and market intelligence to support decision making.

IQ Capital is a European deep tech venture capital firm headquartered in Cambridge, United Kingdom, with activity across the United Kingdom and Europe. It backs early-stage technology companies that advance frontier technologies such as artificial intelligence, energy, computation, biology, and robotics. The firm supports founders from pre-seed to Series A and provides follow-on capital up to 40 million dollars, leveraging a deep technical network to offer strategic guidance and resources. IQ Capital emphasizes rigorous technical understanding and collaborative support to help portfolio companies achieve product-market fit and scale globally. It has backed over 200 startups to date and has facilitated partnerships and potential exits with major technology players.

College Green Ventures is a venture capital firm founded in 2023 and based in Belfast, United Kingdom. It invests in early-stage university spinouts in deep technology and healthcare sectors.

Route 66 Ventures is a private investment firm based in Alexandria, Virginia, providing venture capital and credit solutions to fintech and related sectors. It backs early and growth-stage companies globally, with a focus on financial technology, digital health and wellness, and technology-enabled services. Its venture capital team funds seed to later-stage companies, while its credit team seeks balance-sheet solutions by purchasing whole loans or providing secured debt facilities to alternative lending platforms. The firm differentiates itself through hands-on involvement, drawing on the founders’ and operators' experience to add value at every growth stage. Since its founding in 2014, Route 66 Ventures has completed more than 500 transactions and deployed over $550 million, building an active portfolio of companies.